Home › Funds › Qube Research & Technologies Ltd › INSM

Qube Research & Technologies Ltd position in INSM

INSMED INC · Health Care

Qube Research & Technologies Ltd reported holding 1,682,334 shares of INSM (INSMED INC) in its Q2 2026 13F filing — a position valued at US$179.4M, representing 0.35% of its reported portfolio and ranking #40 among its reported holdings. Qube Research & Technologies Ltd has disclosed INSM holdings in 8 of the last 11 reported quarters, going back to Q4 2023.

Latest position (Q2 2026)1.68M sh
Reported value held$179.37M
Portfolio Weight0.35%
First reportedQ4 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Qube Research & Technologies Ltd's INSM position evolved

Qube Research & Technologies Ltd first disclosed a stake in INSM in Q4 2023 at 20,397 shares (US$632K). The position peaked in Q3 2025 at 1,544,315 shares, worth US$222.4M. Across 8 filings, Qube Research & Technologies Ltd increased the stake 3 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 1,682,334 shares valued at US$179.4M — an increase of 1,533,819 shares quarter over quarter.. Notable position changes include a 64% increase in Q1 2024 (shares rose 147% over the following quarter), a 43% increase in Q3 2025 (shares rose 24% over the following quarter), a 1033% increase in Q2 2026 (shares rose 12% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2023 20.40K $632.10K New
Q1 2024 33.50K $908.86K Add
Q3 2024 489.31K $35.72M New
Q4 2024 389.03K $26.86M Reduce
Q2 2025 1.08M $108.90M New
Q3 2025 1.54M $222.40M Add
Q1 2026 148.51K $24.29M New
Q2 2026 1.68M $179.37M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About INSM and 13F data

INSM (INSMED INC) is a Health Care company. 39 other funds we track also report a position in INSM — the largest reported positions include BAKER BROS. ADVISORS LP (US$937.8M), Darwin Global Management, Ltd. (US$673.6M), Orbis Allan Gray Ltd (US$647.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding INSM

All INSM fund holders →

FAQ

How long has Qube Research & Technologies Ltd held INSM?

Qube Research & Technologies Ltd has disclosed INSM holdings in 8 of the last 11 reported quarters, going back to Q4 2023.

What is Qube Research & Technologies Ltd's current position in INSM?

As of Q2 2026, Qube Research & Technologies Ltd holds 1.68M shares of INSM (INSMED INC), valued at $179.37M, representing 0.35% of its reported portfolio and ranking #40.

Has Qube Research & Technologies Ltd been buying or selling INSM?

In the latest 13F filing (Q2 2026), Qube Research & Technologies Ltd increased its position in INSM. The position peaked in Q3 2025 at 1.54M shares.

Which other funds hold INSM?

Other major institutional holders of INSM include BAKER BROS. ADVISORS LP, Darwin Global Management, Ltd., Orbis Allan Gray Ltd, among 39 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.